Both in Biotechnology
Revolution Medicines vs Neurocrine Biosciences
Over the past year RVMD returned +241.0% and NBIX returned +16.0%; their daily moves had a correlation of 0.20.
RVMD +241.0% NBIX +16.0%Growth of $1, one year, split-adjusted
| Metric | RVMD | NBIX |
|---|---|---|
| Price | $199.70 | $166.05 |
| Market cap | $42.80B | $16.88B |
| Today | +2.82% | +0.73% |
| 1 month | −0.1% | +14.1% |
| 6 months | +32.2% | +12.9% |
| Year to date | +150.7% | +17.1% |
| 1 year | +236.6% | +17.0% |
| Revenue growth (YoY) | — | +41.2% |
| Gross margin | — | 97.6% |
| Net margin | — | 18.4% |
| P/E (TTM) | — | 24.0× |
| Price / sales | — | 4.6× |
| Net cash | $3.45B | $737.9M |
| Dividend yield | — | — |
| Volatility (60d) | 39.9% | 36.5% |
| Short % of float | 6.4% | 6.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).